Replies to post #4026 on Radient Pharmaceuticals Corporation fka RXPC

[Gold Seeker]

Doc, I do not think Adam can refute anything about the new studies because Radient essentially did not give any information to refute. All they said was it had a significant advantage over CEA in early stage. They did not say how good it was in early stage so you do not know if doctors would even use it.

Keep in mind, they knew it beat CEA so they know how it performed. Why did they not tell you?

[primarywatcher]

Thank you Doc, for all the magnificent comments and questions.